210 related articles for article (PubMed ID: 36246869)
41. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
Harno E; Cottrell EC; Yu A; DeSchoolmeester J; Gutierrez PM; Denn M; Swales JG; Goldberg FW; Bohlooly-Y M; Andersén H; Wild MJ; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Dec; 154(12):4580-93. PubMed ID: 24169553
[TBL] [Abstract][Full Text] [Related]
42. Sleeve gastrectomy rapidly enhances islet function independently of body weight.
Douros JD; Niu J; Sdao S; Gregg T; Fisher-Wellman K; Bharadwaj M; Molina A; Arumugam R; Martin M; Petretto E; Merrins MJ; Herman MA; Tong J; Campbell J; D'Alessio D
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30777938
[TBL] [Abstract][Full Text] [Related]
43. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
[TBL] [Abstract][Full Text] [Related]
44. Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
Metabolism; 2012 Jun; 61(6):823-35. PubMed ID: 22209663
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
[TBL] [Abstract][Full Text] [Related]
46. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
[TBL] [Abstract][Full Text] [Related]
47. Effect of 11β-HSD1 dehydrogenase activity on bone histomorphometry of glucocorticoid-induced osteoporotic male Sprague-Dawley rats.
Elvy Suhana MR; Farihah HS; Faizah O; Nazrun AS; Norazlina M; Norliza M; Ima-Nirwana S
Singapore Med J; 2011 Nov; 52(11):786-93. PubMed ID: 22173247
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms underlying the efficacy of a rodent model of vertical sleeve gastrectomy - A focus on energy expenditure.
Stefanidis A; Lee CMC; Greaves E; Montgomery MK; Arnold M; Newn S; Budin AJ; Lemus MB; Foldi CJ; Burton PR; Brown WA; Lutz TA; Watt MJ; Oldfield BJ
Mol Metab; 2023 Jul; 73():101739. PubMed ID: 37187239
[TBL] [Abstract][Full Text] [Related]
49. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
50. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
[TBL] [Abstract][Full Text] [Related]
51. Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control.
Douros JD; Niu J; Sdao S; Gregg T; Merrins MJ; Campbell J; Tong J; D'Alessio D
Mol Metab; 2019 Oct; 28():144-150. PubMed ID: 31326351
[TBL] [Abstract][Full Text] [Related]
52. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
Liu Y; Nakagawa Y; Wang Y; Liu L; Du H; Wang W; Ren X; Lutfy K; Friedman TC
J Mol Endocrinol; 2008 Aug; 41(2):53-64. PubMed ID: 18524870
[TBL] [Abstract][Full Text] [Related]
53. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
[TBL] [Abstract][Full Text] [Related]
54. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
[TBL] [Abstract][Full Text] [Related]
55. Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.
Balachandran A; Guan H; Sellan M; van Uum S; Yang K
Endocrinology; 2008 Aug; 149(8):4069-79. PubMed ID: 18467433
[TBL] [Abstract][Full Text] [Related]
56. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
57. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
[TBL] [Abstract][Full Text] [Related]
58. 11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes.
Peng K; Pan Y; Li J; Khan Z; Fan M; Yin H; Tong C; Zhao Y; Liang G; Zheng C
Sci Rep; 2016 Nov; 6():37160. PubMed ID: 27841334
[TBL] [Abstract][Full Text] [Related]
59. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
[TBL] [Abstract][Full Text] [Related]
60. Lipocalin-type prostaglandin D
Kumar S; Lau R; Hall CE; Palaia T; Rideout DA; Brathwaite CE; Ragolia L
Surg Obes Relat Dis; 2016; 12(8):1523-1531. PubMed ID: 27425837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
